All Blogs

Mar 11, 2021

Valo Health receives $110M Series B Cognito’s therapy slows Alzheimer’s disease Ventyx Biosciences raises $114M Takeda expands immuno-oncology portfolio


Mar 10, 2021

Diagnosing At-Home: Are At-Home Diagnostic Tools The New Trends?


Mar 09, 2021

Overwhelming success of Gilead/Kite’s Yescarta; Ridgeback/ Merck in the COVID-19 game; AnaptysBio’s antibody-drug failure; Roche discards Tecentriq for bladder cancer


Mar 08, 2021

A Royal Disease: Hemophilia


Mar 05, 2021

Rare Cancer Market: A Global Crusade on what is a ‘less common cancer’?


Mar 04, 2021

Novavax targets COVID-19 approval; Iktos collaborates with Pfizer; AbbVie bags option to acquire Mitokinin; Presage inks new pact with Merck


Mar 03, 2021

Applications of AI in Healthcare: COVID-19 and Beyond


Mar 02, 2021

Evotec, Chinook Teams Up for CKD Therapy; HitGen & UPPTHERA in Drug Delivery Research; Artiva’s $120 M Coup of NK Cell Therapy; Junshi & AZ with Toripalimab in China


Mar 01, 2021

What are the Market Drivers Fueling the Rare Disease Market?


Feb 26, 2021

Gene and Cell Therapies in CNS Disorders: Miracle Cure? Opportunities Galore!